The U.S. Food and Drug Administration (FDA) has officially granted approval for ViiV Healthcare’s Tivicay PD (dolutegravir) for the treatment…
Read More

The U.S. Food and Drug Administration (FDA) has officially granted approval for ViiV Healthcare’s Tivicay PD (dolutegravir) for the treatment…
Read More
The software development landscape is undergoing a structural transformation as artificial intelligence transitions from experimental autocomplete utilities to autonomous coding…
Read More
The U.S. Food and Drug Administration (FDA) has granted a significant regulatory expansion for ViiV Healthcare’s Tivicay PD (dolutegravir), a…
Read More
A History of Pediatric Antiretroviral Evolution The journey toward this approval reflects a decade of clinical progress in pediatric HIV…
Read More
The U.S. Food and Drug Administration (FDA) has officially granted approval for ViiV Healthcare’s Tivicay PD (dolutegravir) to treat HIV-1…
Read More
The biological toll of long-duration spaceflight has long been a concern for space agencies worldwide, but new research from Johns…
Read More